Checkpoint Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Checkpoint Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
  • Checkpoint Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$6.67M, a 58.8% increase year-over-year.
  • Checkpoint Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$35.5M, a 42.4% increase year-over-year.
  • Checkpoint Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$52.1M, a 10.6% increase from 2022.
  • Checkpoint Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$58.3M, a 2.84% decline from 2021.
  • Checkpoint Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$56.7M, a 144% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$52.1M +$6.19M +10.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 -$58.3M -$1.61M -2.84% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 -$56.7M -$33.5M -144% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$23.2M +$1.65M +6.64% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 -$24.9M +$11.9M +32.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$36.7M -$14M -61.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 -$22.8M -$611K -2.76% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$22.2M -$8.94M -67.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 -$13.2M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.